Establishment Labs to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Establishment Labs Holdings (NASDAQ: ESTA), a global medical technology company focused on women's health and wellness, particularly in breast aesthetics and reconstruction, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. Juan José Chacón-Quirós, Founder and CEO, and Raj Denhoy, CFO, will deliver a presentation on Wednesday, January 15, 2025, at 3:45 p.m. Pacific Time.
The presentation will be accessible via live webcast on the company's investor relations website at investors.establishmentlabs.com. An archived version will also be made available after the event.
Establishment Labs Holdings (NASDAQ: ESTA), una società globale di tecnologia medica focalizzata sulla salute e il benessere delle donne, in particolare nell'estetica e nella ricostruzione mammaria, ha annunciato la sua partecipazione al 43º Conferenza Annuale J.P. Morgan Healthcare. Juan José Chacón-Quirós, Fondatore e CEO, e Raj Denhoy, CFO, presenteranno il loro intervento mercoledì 15 gennaio 2025, alle 15:45 ora del Pacifico.
La presentazione sarà accessibile tramite webcast dal vivo sul sito web delle relazioni con gli investitori della società all'indirizzo investors.establishmentlabs.com. Una versione archiviata sarà disponibile anche dopo l'evento.
Establishment Labs Holdings (NASDAQ: ESTA), una empresa global de tecnología médica centrada en la salud y el bienestar de las mujeres, particularmente en la estética y reconstrucción mamaria, ha anunciado su participación en la 43ª Conferencia Anual de J.P. Morgan Healthcare. Juan José Chacón-Quirós, Fundador y CEO, y Raj Denhoy, CFO, realizarán una presentación el miércoles 15 de enero de 2025, a las 3:45 p.m. hora del Pacífico.
La presentación estará disponible a través de una transmisión web en vivo en el sitio web de relaciones con inversores de la empresa en investors.establishmentlabs.com. También se hará disponible una versión archivada después del evento.
Establishment Labs Holdings (NASDAQ: ESTA)는 여성의 건강과 웰빙, 특히 유방 미용과 재건에 초점을 맞춘 글로벌 의료 기술 회사로, 제43회 연례 J.P. Morgan Healthcare 컨퍼런스에 참가한다고 발표했습니다. Juan José Chacón-Quirós 창립자 겸 CEO와 Raj Denhoy CFO가 2025년 1월 15일 수요일, 태평양 표준시 오후 3:45에 발표를 진행할 예정입니다.
이번 발표는 회사를 위한 투자자 관계 웹사이트인 investors.establishmentlabs.com에서 생중계로 확인할 수 있습니다. 행사 후 아카이브된 버전도 제공될 예정입니다.
Establishment Labs Holdings (NASDAQ: ESTA), une entreprise mondiale de technologie médicale axée sur la santé et le bien-être des femmes, notamment en matière d'esthétique et de reconstruction mammaire, a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan Healthcare. Juan José Chacón-Quirós, fondateur et PDG, et Raj Denhoy, directeur financier, présenteront le mercredi 15 janvier 2025, à 15h45, heure du Pacifique.
La présentation sera accessible via un webcast en direct sur le site Web des relations avec les investisseurs de l'entreprise à l'adresse investors.establishmentlabs.com. Une version archivée sera également disponible après l'événement.
Establishment Labs Holdings (NASDAQ: ESTA), ein globales Medizintechnikunternehmen, das sich auf die Gesundheit und das Wohlbefinden von Frauen konzentriert, insbesondere in den Bereichen Brustästhetik und -rekonstruktion, hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare-Konferenz angekündigt. Juan José Chacón-Quirós, Gründer und CEO, und Raj Denhoy, CFO, werden am Mittwoch, den 15. Januar 2025, um 15:45 Uhr pazifischer Zeit eine Präsentation halten.
Die Präsentation wird live über ein Webcast auf der Investor-Relations-Website des Unternehmens unter investors.establishmentlabs.com zugänglich sein. Eine archivierte Version wird nach der Veranstaltung ebenfalls verfügbar sein.
- None.
- None.
A live webcast of the presentation will be available on the Establishment Labs investor relations website at https://investors.establishmentlabs.com/. An archived version of the webcast will be available on the same website following completion of the event.
About Establishment Labs
Establishment Labs Holdings Inc. is a global medical technology company dedicated to improving women’s health and wellness through the power of science, engineering, and technology. The Company offers a portfolio of Femtech solutions for breast health, breast aesthetics and breast reconstruction. The nearly four million Motiva® devices Establishment Labs has delivered to plastic and reconstructive surgeons since 2010 have created a new standard for safety and patient satisfaction in the over 85 countries in which they are available. The Motiva Flora® tissue expander is used to improve outcomes in breast reconstruction following breast cancer and it is the only regulatory-approved expander in the world with an integrated port using radio-frequency technology that is MRI conditional. Mia Femtech™, Establishment Lab’s unique minimally invasive experience for breast harmony, is the Company’s most recent breakthrough innovation. These solutions are supported by over 200 patent applications in 20 separate patent families worldwide and over 100 scientific and clinical studies and publications in peer reviewed journals. Establishment Labs manufactures at two facilities in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250107356947/en/
Investor/Media Contact:
Raj Denhoy
415-828-1044
rdenhoy@establishmentlabs.com
Source: Establishment Labs Holdings Inc.
FAQ
When is Establishment Labs (ESTA) presenting at the JP Morgan Healthcare Conference 2025?
How can investors watch Establishment Labs' (ESTA) JP Morgan Healthcare Conference presentation?
Who will represent Establishment Labs (ESTA) at the 2025 JP Morgan Healthcare Conference?
What is the main business focus of Establishment Labs (ESTA)?
